Skip to main content

Advertisement

Log in

Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

An Erratum to this article was published on 25 February 2011

Abstract

Background

Preoperative chemoradiation can potentially improve outcomes in patients with pancreatic cancer. This study addresses its effect on staging pancreatic cancer with multidetector computed tomography (MDCT).

Methods

Fifty-five patients underwent a dual-phase MDCT pancreas protocol for proved pancreatic cancer. Of these, 16 patients underwent preoperative chemoradiation. Three radiologists independently reviewed images to assess for locally advanced disease, liver and peritoneal metastases on baseline studies of all 55 patients, and on follow-up preoperative studies for the 16 patients receiving preoperative therapy. Overall score for resectability was graded on a scale from 1 to 5 (1, definitely resectable; 5. definitely unresectable). Receiver operating characteristic curves and weighted (κ statistics were determined.

Results

The areas under the receiver operating characteristic curves for readers 1, 2, and 3 were 0.98, 0.96, and 0.90, respectively. Weighted κ values for reader 1 versus reader 2, reader 1 versus reader 3, and reader 2 versus reader 3 were 0.90, 0.57, and 0.54, respectively. Interpreting scores of 1 to 3 for resectability as resectable disease, the mean values for sensitivity, specificity, negative predictive value, positive predictive value, and accuracy were 0.92, 0.91, 0.74, 0.98, and 0.92 respectively.

Conclusion

The negative predictive value for MDCT for identifying unresectable pancreatic cancer in the setting of preoperative therapy is comparable to that reported in the absence of neoadjuvant therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Jemal A, Tiwari RC, Murray T, et al. (2004) Cancer statistics, 2004. CA Cancer J Clin 54:8–29

    Article  PubMed  Google Scholar 

  2. Trede M, Schwall G, Saeger H-D (1990) Survival after pancreatoduodenectomy. Ann Surg 211:447–458

    Article  PubMed  CAS  Google Scholar 

  3. Lowenfels A, Maisonneuve P, Boyle P (1998) Epidemiology of pancreatic cancer. In: Howard J, Idezuki Y, Ihse I, Prinz R, eds. Surgical disease of the pancreas, 3rd ed. Baltimore: Williams & Wilkins, 433–437

    Google Scholar 

  4. Douglass HJ, Kim S, Meropol N (1997) Neoplasms of the exocrine pancreas. In: Holland J, Frei EI, Bast RJ, eds. Cancer medicine, 4th ed. Baltimore: Williams & Wilkins, 1989–2018

    Google Scholar 

  5. Evans DB, Abbruzzese JL, Willett CG (2001) Cancer of the pancreas. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer, principles and practice of oncology, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 1126–1161

    Google Scholar 

  6. Staley CA, Lee JE, Cleary KR, et al. (1996) Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 171:115–124

    Article  Google Scholar 

  7. Neoptolemos JP, Dunn JA, Stocken DD, et al. (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358:1576–1585

    Article  PubMed  CAS  Google Scholar 

  8. Kalser MH, Ellenberg SS (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899–903

    PubMed  CAS  Google Scholar 

  9. Burris HA III, Moore MJ, Andersen J, et al. (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413

    PubMed  CAS  Google Scholar 

  10. Mason KA, Milas L, Hunter NR, et al. (1999) Maximizing therapeutic gain with gemcitabine and fractionated radiation. Int J Radiat Oncol Biol Phys 44:1125–1135

    Article  PubMed  CAS  Google Scholar 

  11. McGinn CJ, Zalupski MM (2003) Radiation therapy with once-weekly gemcitabine in pancreatic cancer: current status of clinical trials. Int J Radiat Oncol Biol Phys 56:10–15

    Article  PubMed  Google Scholar 

  12. Breslin TM, Janjan NA, Lee JE, et al. (1998) Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Front Biosci 3:E193–E203

    PubMed  CAS  Google Scholar 

  13. Evans DB, Pisters PW, Lee JE, et al. (1998) Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. J Hepatobiliary Pancreat Surg 5:242–250

    Article  PubMed  CAS  Google Scholar 

  14. Pisters PW, Hudec WA, Lee JE, et al. (2000) Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. J Clin Oncol 18:860–867

    PubMed  CAS  Google Scholar 

  15. Janjan NA, Crane CN, Feig BW, et al. (2000) Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 47:713–718

    Article  PubMed  CAS  Google Scholar 

  16. Breslin TM, Hess KR, Harbison DB, et al. (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8:123–132

    Article  PubMed  CAS  Google Scholar 

  17. Wolff RA, Evans DB, Gravel DM, et al. (2001) Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res 7:2246–2253

    PubMed  CAS  Google Scholar 

  18. Crane C, Janjan N, Evans D, et al. (2001) Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Gastrointest Cancer 29:9–18

    Article  PubMed  CAS  Google Scholar 

  19. Wolff RA, Evans DB, Crane CH, et al. (2002) Initial results of preoperative gemcitabine (GEM)–based chemoradiation for resectable pancreatic adenocarcinoma. Orlando, FL: American Society of Clinical Oncology

    Google Scholar 

  20. Diehl SJ, Lehmann KJ, Sadick M, et al. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 206:373–378

    PubMed  CAS  Google Scholar 

  21. Valls C, Andia E, Sanchez A, et al. (2002) Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR 178:821–826

    PubMed  Google Scholar 

  22. McCarthy MJ, Evans J, Sagar G, Neoptolemos JP (1998) Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg 85:320–325

    Article  PubMed  CAS  Google Scholar 

  23. Loyer EM, David CL, Dubrow RA, et al. (1996) Vascular involvement in pancreatic adenocarcinoma: reassessment by thin- section CT. Abdom Imaging 21:202–206

    Article  PubMed  CAS  Google Scholar 

  24. Kim T, Murakami T, Takahashi S, et al. (1999) Pancreatic CT imaging: effects of different injection rates and doses of contrast material. Radiology 212:219–225

    PubMed  CAS  Google Scholar 

  25. National Comprehensive Cancer Network I (2004) Clinical practice guidelines in oncology: pancreatic adenocarcinoma. National Comprehensive Cancer Network, PA, USA, http://www.nccn.org/professionals/physician_gls/PDF/pancreatic.pdf

    Google Scholar 

  26. Exocrine pancreas. In: Greene F, Page D, Fleming I, et al. (eds) (2002) AJCC cancer staging manual, 6th ed. New York: Springer-Verlag, 157–164

    Google Scholar 

  27. Freeny PC, Traverso LW, Ryan JA (1993) Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg 165:600–606

    Article  PubMed  CAS  Google Scholar 

  28. Bluemke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385

    PubMed  CAS  Google Scholar 

  29. Tabuchi T, Itoh K, Ohshio G, et al. (1999) Tumor staging of pancreatic adenocarcinoma using early- and late-phase helical CT. AJR 173:375–380

    PubMed  CAS  Google Scholar 

  30. Warshaw AL, Fernandez-del Castillo C (1992) Pancreatic carcinoma. N Engl J Med 326:455–465

    Article  PubMed  CAS  Google Scholar 

  31. van Delden OM, de Wit LT, Nieveen van Dijkum EJ, et al. (1998) Laparoscopic ultrasonography for abdominal tumor staging. Eur Radiol 8:1405–1408

    Article  PubMed  Google Scholar 

  32. Jimenez RE, Warshaw AL, Fernandez-Del Castillo C (2000) Laparoscopy and peritoneal cytology in the staging of pancreatic cancer. J Hepatobiliary Pancreat Surg 7:15–20

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. P. Tamm.

Additional information

An erratum to this article can be found online at http://dx.doi.org/10.1007/s00261-011-9702-4

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tamm, E.P., Loyer, E.M., Faria, S. et al. Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. Abdom Imaging 31, 568–574 (2006). https://doi.org/10.1007/s00261-005-0194-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-005-0194-y

Keywords

Navigation